Pain in peripheral arteriography-a comparison of a low osmolality contrast medium with a conventional compound.
The pain reaction to a new low osmolality contrast agent, sodium-methyl-glucamine-ioxaglate, in comparison to the conventional compound methylglucamine-ioxitalamate was tested and statistically evaluated in 12 patients using the visual analogue scale method. The intensity of pain experienced was significantly smaller following intra-arterial injection of the compound of low osmolality as compared to the conventional contrast agent.
D000328:Adult; D000368:Aged; D000792:Angiography / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D007463:Iodobenzoates / Q000009:adverse effects*; D007482:Iothalamate Meglumine / Q000009:adverse effects / Q000031:analogs & derivatives*; D008297:Male; D008536:Meglumine / Q000009:adverse effects / Q000031:analogs & derivatives; D008875:Middle Aged; D009994:Osmolar Concentration; D010146:Pain / Q000209:etiology*; D011897:Random Allocation; D014283:Triiodobenzoic Acids / Q000009:adverse effects*
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D008536:Meglumine; D007482:Iothalamate Meglumine